Major Organoids Companies Plus Latest TechBio News
The latest TechBio briefing spotlights the fastest‑growing private organoid firms, highlighting recent Series A‑C rounds that collectively raised over $500 million. Leaders such as OrganoTech, CellSphere, and BioMimic are scaling production pipelines to meet demand from pharma, diagnostics, and personalized‑medicine partners. The piece also notes strategic collaborations with major academic labs and the rollout of next‑generation microfluidic platforms that improve tissue fidelity. Overall, the sector is transitioning from niche research tools to commercial‑grade, scalable therapeutics platforms.
Latest TechBio News
Evotec SE announced that its Seattle CDMO, Just‑Evotec Biologics, has been selected by BARDA’s BioMaP‑Consortium for a multi‑year, up‑to‑$10 million program to optimize manufacturing of a monoclonal‑antibody cocktail against Ebola and Sudan viruses. The same day, Evotec disclosed that partner Bristol...
Brain TechBio 🧠🖥️ (ΙIΙ)
The latest Brain TechBio roundup highlights several breakthroughs across neurotechnology and AI-driven drug discovery. Angelini Pharma has inked a multi‑year deal with Quiver Bioscience, offering up to $120 million in milestones for AI‑guided epilepsy treatments. In India, KIMS Hospitals introduced adaptive...
Latest TechBio News
Proscia has been crowned the top‑performing digital pathology software vendor in the United States, receiving a 95.2 overall score in KLAS Research’s 2026 report and earning A+ or A grades across all six customer‑experience pillars. The company is also the...
Organoids and Artificial Intelligence 🫐
The episode explores the rapid convergence of organoid technology and artificial intelligence, highlighting how AI-driven image analysis, multidimensional data integration, and high‑throughput screening are transforming organoid research. It introduces the emerging field of Organoid Intelligence, where brain organoids act as...
Latest on TechBio News
The episode highlights Proscia’s recent achievements, including being named the Global 2026 Best in KLAS for Digital Pathology in Europe and a series of product and partnership milestones such as new AI tools for skin biomarkers, virtual staining, and integration...
Blood Glucose Monitoring
The episode explores how AI and machine learning are reshaping blood glucose monitoring, moving from invasive blood draws toward non‑invasive analysis of sweat, saliva, and interstitial fluid. It highlights advances such as Raman spectroscopy combined with AI to interpret complex...
Weekly TechBio News 🌟🎄
This episode highlights four major tech‑bio developments: Egypt’s Nawah Scientific secured $23 million to expand its remote "cloud lab" platform into Rwanda and Saudi Arabia while scaling operations in Egypt; UpCloud opened a new data center in Copenhagen to boost low‑latency...
Weekly TechBio News
The episode highlights four major tech‑bio developments: LatchBio’s launch of agent.bio, an interactive sandbox for spatial biology analysis across five platforms; Chai Discovery’s $130 M Series B raise to build an AI‑driven CAD suite for drug design, backed by OpenAI; Accenture Ventures’...